申請護照 has not formally responded to the Chinese determination yet. Though the Nepal authorities granted approval for emergency use of the vaccine developed by China's Sinopharm on February 18, the lack of correct documentation of its trial outcomes and logistic points has prevented its rollout for bigger public use. Different
